{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:20Z","timestamp":1794047360678,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2019.244418","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T10:54:37Z","timestamp":1593082477000},"page":"1172-1177","source":"Crossref","is-referenced-by-count":6,"title":["Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma."],"prefix":"10.3324","volume":"106","author":[{"family":"Keiichiro Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ariunzaya Bat-Erdene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hirofumi Tenshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Qu Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jumpei Teramachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Masahiro Hiasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Asuka Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Takeshi Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hirokazu Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kimiko Sogabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Masahiro Oura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ryohei Sumitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yukari Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Itsuro Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Eiji Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Makoto Kawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hiroyuki Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Toshio Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Masahiro Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"24438","doi-asserted-by":"crossref","unstructured":"Abe M, Hiura K, Wilde J. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood. 2004; 104(8):2484-2491.","DOI":"10.1182\/blood-2003-11-3839"},{"key":"24439","doi-asserted-by":"crossref","unstructured":"Lawson MA, McDonald MM, Kovacic N. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat Commun. 2015; 6:8983.","DOI":"10.1038\/ncomms9983"},{"key":"24440","doi-asserted-by":"crossref","unstructured":"Nakano A, Miki H, Nakamura S. Up-regulation of hexokinase II in myeloma cells: targeting myeloma cells with 3-bromopyruvate. J Bioenerg Biomembr. 2012; 44(1):31-38.","DOI":"10.1007\/s10863-012-9412-9"},{"key":"24441","doi-asserted-by":"crossref","unstructured":"Ji K, Mayernik L, Moin K, Sloane BF. Acidosis and proteolysis in the tumor microenvironment. Cancer Metastasis Rev. 2019; 38(1-2):103-112.","DOI":"10.1007\/s10555-019-09796-3"},{"key":"24442","doi-asserted-by":"crossref","unstructured":"Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289(5484):1504-1508.","DOI":"10.1126\/science.289.5484.1504"},{"key":"24443","doi-asserted-by":"crossref","unstructured":"Amachi R, Hiasa M, Teramachi J. A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration. Oncotarget. 2016; 7(43):70447-70461.","DOI":"10.18632\/oncotarget.11927"},{"key":"24444","doi-asserted-by":"crossref","unstructured":"Gerweck LE, Vijayappa S, Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther. 2006; 5(5):1275-1279.","DOI":"10.1158\/1535-7163.MCT-06-0024"},{"key":"24445","unstructured":"Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989; 49(16):4373-4384."},{"key":"24446","doi-asserted-by":"crossref","unstructured":"Kawatani M, Osada H. Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases. Cancer Sci. 2009; 100(11):1999-2005.","DOI":"10.1111\/j.1349-7006.2009.01294.x"},{"key":"24447","doi-asserted-by":"crossref","unstructured":"Woo JT, Kawatani M, Kato M. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Proc Natl Acad Sci U S A. 2006; 103(12):4729-4734.","DOI":"10.1073\/pnas.0505663103"},{"key":"24448","doi-asserted-by":"crossref","unstructured":"Muguruma H, Yano S, Kakiuchi S. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin Cancer Res. 2005; 11(24 Pt 1):8822-8828.","DOI":"10.1158\/1078-0432.CCR-05-1335"},{"key":"24449","doi-asserted-by":"crossref","unstructured":"Takeuchi K, Abe M, Hiasa M. Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth. PLoS One. 2010; 5(3):e9870.","DOI":"10.1371\/journal.pone.0009870"},{"key":"24450","doi-asserted-by":"crossref","unstructured":"Fulciniti M, Amin S, Nanjappa P. Significant biological role of sp1 transactivation in multiple myeloma. Clin Cancer Res. 2011; 17(20):6500-6509.","DOI":"10.1158\/1078-0432.CCR-11-1036"},{"key":"24451","doi-asserted-by":"crossref","unstructured":"Bat-Erdene A, Miki H, Oda A. Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors. Oncotarget. 2016; 7(48):79064-79075.","DOI":"10.18632\/oncotarget.12594"},{"key":"24452","doi-asserted-by":"crossref","unstructured":"Asano J, Nakano A, Oda A. The serine\/threonine kinase Pim- 2 is a novel anti-apoptotic mediator in myeloma cells. Leukemia. 2011; 25(7):1182-1188.","DOI":"10.1038\/leu.2011.60"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9790\/70991","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9790\/70992","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9790\/70991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:57:27Z","timestamp":1794045447000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.244418","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}